ISOTYPE-SPECIFIC REGULATION OF MHC CLASS-II GENE-EXPRESSION IN HUMAN MONOCYTES BY EXOGENOUS AND ENDOGENOUS TUMOR-NECROSIS-FACTOR

被引:25
作者
JASINSKI, M [1 ]
WIECKIEWICZ, J [1 ]
RUGGIERO, I [1 ]
PITUCHNOWOROLSKA, A [1 ]
ZEMBALA, M [1 ]
机构
[1] JAGIELLONIAN UNIV,POLISH AMER CHILDRENS HOSP,COLL MED,DEPT CLIN IMMUNOL,PL-30663 KRAKOW,POLAND
关键词
HUMAN MONOCYTES; TNF; MHC CLASS II; TNF-RECEPTORS; THALIDOMIDE;
D O I
10.1007/BF01541088
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The control of expression of MHC class II molecules on antigen-presenting cells is important for the induction of immunity, while aberrant expression of these molecules plays a role in the immunopathology of autoimmune diseases. This study explored the role of tumor necrosis factor alpha (TNF) in controlling the level of HLA class II mRNA in human monocytes. Exposure of monocytes to exogenous recombinant TNF (rTNF) selectively up-regulated DR (alpha-mRNA but not DP or DQ alpha-mRNA. Inhibitors of TNF synthesis, pentoxifylline (PTX) and thalidomide, inhibited TNF mRNA accumulation in LPS-activated monocytes and down-regulated DR mRNA but not DP or DQ mRNA. The inhibitory effect of anti-TNF monoclonal antibody (MAb) indicated that endogenously generated TNF acted extracellularly. Anti-p75 TNF-R2 receptor and to a lesser extent anti-p55 TNF-R1 MAbs inhibited TNF-mediated up-regulation of DR mRNA and TNF mRNA. Taken together, this implies that endogenously generated TNF plays a role in controlling isotype-specific MHC class II gene expression in human monocytes/macrophages. These results may have some implications for anti-tumor response and autoimmunity.
引用
收藏
页码:185 / 193
页数:9
相关论文
共 40 条
[1]  
ANICHINI A, 1988, J IMMUNOL, V140, P183
[2]   FUNCTIONAL-SIGNIFICANCE OF THE REGULATION OF MACROPHAGE-IA EXPRESSION [J].
BELLER, DI .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (02) :138-143
[3]   ASSOCIATION BETWEEN HLA-DR2 AND PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1 BY MONONUCLEAR-CELLS ACTIVATED BY LIPOPOLYSACCHARIDE [J].
BENDTZEN, K ;
MORLING, N ;
FOMSGAARD, A ;
SVENSON, M ;
JAKOBSEN, B ;
ODUM, N ;
SVEJGAARD, A .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (05) :599-606
[4]  
BOTTAZZO GF, 1983, LANCET, V2, P1115
[5]   IDENTIFICATION OF 2 TYPES OF TUMOR-NECROSIS-FACTOR RECEPTORS ON HUMAN CELL-LINES BY MONOCLONAL-ANTIBODIES [J].
BROCKHAUS, M ;
SCHOENFELD, HJ ;
SCHLAEGER, EJ ;
HUNZIKER, W ;
LESSLAUER, W ;
LOETSCHER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (08) :3127-3131
[6]  
CAMPBELL IL, 1988, J IMMUNOL, V140, P1111
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   CYTOKINE GENE-TRANSFER IN TUMOR-INHIBITION AND TUMOR-THERAPY - WHERE ARE WE NOW [J].
COLOMBO, MP ;
FORNI, G .
IMMUNOLOGY TODAY, 1994, 15 (02) :48-51
[9]   MOLECULAR MAPPING OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX BY PULSED-FIELD GEL-ELECTROPHORESIS [J].
DUNHAM, I ;
SARGENT, CA ;
TROWSDALE, J ;
CAMPBELL, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (20) :7237-7241
[10]  
FERTSCH D, 1987, J IMMUNOL, V139, P244